Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /301507

Hangzhou Minsheng Healthcare Co., Ltd.

301507

• SHE: 301507 • Delayed

14.76CNY 0.8%

2.18 USD

As of 12 June 2026, Hangzhou Minsheng Healthcare Co., Ltd. has a market cap of $771.06M USD, ranking #12284 globally and #3650 in China. It ranks #1125 in the Healthcare sector, and #65 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

12284

Country Rank

3650

Sector Rank

1125

Industry Rank

Key Stats

Market Cap

$771.06MUSD

5.22B CNY

Enterprise Value

$664.3MUSD

4.5B CNY

Revenue (TTM)

$122.17MUSD

827.65M CNY

EBITDA (TTM)

$19.37MUSD

131.19M CNY

Net Income (TTM)

$17.55MUSD

118.86M CNY

EBITDA Margin

16%

Profit Margin

14%

PE Ratio

44.4

PS Ratio

6.3

PB Ratio

3.0

EV/EBITDA

33.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Haijun Zhang open_in_new

Employees

514

Founded

1926

Website

hzmsjk.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.8%	2.4%	2.4%	-5.9%	2.5%	-4.6%	12%	-63%	-63%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301507 杭州民生健康药业股份有限公司 Class A Shares ISIN: CNE1000068Q3 Shares Out.: Shares Outstanding: 354.213M¹ Shares Float: 354.209M² TV: TradingView: SZSE: 301507 SA: Stock Analysis: SHE: 301507 YF: Yahoo Finance: 301507.SZ GF: Google Finance: SHE: 301507 BA: Barron's: 301507 MS: Morningstar: XSHE: 301507	14.76 CNY	TV: TradingView: SZSE: 301507 SA: Stock Analysis: SHE: 301507 YF: Yahoo Finance: 301507.SZ GF: Google Finance: SHE: 301507 BA: Barron's: 301507 MS: Morningstar: XSHE: 301507

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hangzhou Minsheng Healthcare Co., Ltd.

Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and health foods in China. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin, vitamin, and zinc selenium with mineral tablets; and glucosamine chondroitin colostrum protein chewable, vitamin soft capsules and chewable, iron folic acid, melatonin, coenzyme soft capsules, and calcium magnesium vitamin D tablets. The company offers its product under the 21 SUPER-VITA brand name. Hangzhou Minsheng Healthcare Co., Ltd. was founded in 1926 and is based in Hangzhou, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 2K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 1K%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 576%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.2B 28.47B CNY 445%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY 324%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY 255%	11.5	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.69B 108.92B ILS 5K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 4K%	-	United States
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 1K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.05B 1.05T INR 1K%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.74B 7.57B EUR 1K%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.47B 807.02B INR 998%	23.1	India

chevron_leftBack